STX2 and hemolytic-uremic syndrome: The observation that co-administering LPS and Stx2 shifted the spectrum of pathological changes in mice to one more closely resembling that observed in HUS victims prompted us to investigate whether LPS would also alter the susceptibility of HuSAP transgenic mice to Stx2 and the results of these investigations are reported herein.